MedTrace Logo

Effect of Interval Cancer and Screening Process on Survival and Disease-free Period in Breast Cancer

NCT03165006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1086

Last updated 2017-05-24

No results posted yet for this study

Summary

This is a multicenter retrospective cohort of women participating in breast cancer screening programs in Spain between 2000 and 2009, with a cancer diagnosed during the screening or between the screening interval (interval cancer), specifically true interval cancers and false negatives. The investigators obtained woman-related information (including breast density), tumor-related information (including tumor phenotype), and follow-up information (including relapses, second neoplasms and vital status at the end of follow up (June 2014)). The objective is to evaluate the survival and disease-free period of women participating in screening programs for breast cancer with a cancer diagnosed during the screening or an interval cancer, specifically true interval cancers and false negatives.

This study is part of a broader project (CAMISS study), which also includes one prospective cohort (CAMISS Prospective cohort - Identifier in ClinicalTrials.gov: NCT02439554).

Conditions

Interventions

PROCEDURE

Mode of detection: Cancer detected at screening

Cancers detected as a result of screening mammograms.

PROCEDURE

Mode of detection: Interval cancer

Cancers diagnosed after a negative screening mammogram and before the next screening invitation (2 years in Spain)

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • European Regional Development Fund

    collaborator OTHER

  • Red de Investigación en Servicios de Salud en Enfermedades Crónicas

    collaborator OTHER

  • Parc de Salut Mar

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2014-06-30
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03165006 on ClinicalTrials.gov